';
HomeServicesTest guidehereditary spherocytosis - screening (eosin-5'-maleimide (EMA) staining) - whole blood
string(5) "28358"

hereditary spherocytosis - screening (eosin-5'-maleimide (EMA) staining) - whole blood Refered Test

Other tests

Biomnis code

EMA

Synonyms

  • Minkowski - Chauffard disease

Clinic significance

Hereditary spherocytosis, or Minkowski-Chauffard syndrome, is a form of congenital chronic haemolytic anaemia resulting from abnormalities in proteins in the red blood cell membrane. Flow cytometry by marking with eosin-5'-maleimide (EMA) of transmembrane proteins is n improved replacement for the osmotic fragility test to diagnose hereditary spherocytosis. It sensitivity is > 90% and its specificity is 89¿99% according to studies.

Preanalytical

  • 5 mL
  • EDTA whole blood
  • Refrigerated

Further information

  • The test must be performed within 72 hours after blood draw
  • ALWAYS attach the specific clinical information form (R39-INTGB :EMA)

Methodology

Flow Cytometry

Turn around Time

10 days


Pathologist(s) in charge
Refered Test
Specialty
Haematology
Contact(s)
Dr Dominique ENGERAND
Dr Léna LE FLEM
Phone(s)
+331 49 59 62 70
+331 49 59 17 44

Caption

Refered TestThe pre-analytical conditions and prices are defined on the basis of the requirements of the performing laboratory.

Eurofins Biomnis uses cookies to offer you the best service. Continuing your navigation, you agree to receive cookies from eurofins-biomnis.com

For more information visit legal notice

Mettez à jour votre navigateur pour consulter ce site